Research Article
Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity
Table 1
In vitro activity of vancomycin alone and with cilastatin against clinical isolates of Staphylococcus aureus and Enterococcus spp.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Table shows the effect of cilastatin (200 g/mL) against inhibitory and bactericidal activity of vancomycin (0–64 g/mL) in clinical bacteria isolated. Staphylococcus aureus: strains numbers 1 and 4, methicillin-resistant; strain numbers 2 and 3, methicillin-susceptible. Enterococcus spp.: strains numbers 5, 7, and 8, E. faecalis; strain number 6, E. faecium. MIC, minimum inhibitory concentration; MBC, minimum bactericidal concentration; vehicle, cation-adjusted Mueller-Hinton broth; cil, cilastatin. |